SPRC - SciSparc Ltd

5.61
0.040   0.713%

Share volume: 30,783
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.20%

PREVIOUS CLOSE
CHG
CHG%
$5.57
0.04
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
0.90%
1 Month
748.71%
3 Months
186.22%
6 Months
209.94%
1 Year
1,302.50%
2 Year
1,416.22%
Key data
Stock price
$5.61
P/E Ratio 
N/A
DAY RANGE
$5.36 - $5.91
EPS 
N/A
52 WEEK RANGE
$0.23 - $8.90
52 WEEK CHANGE
$1,458.33
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$124,135
AVERAGE 30 VOLUME 
$91,177
Company detail
CEO: Oz Adler
Region: US
Website: scisparc.com
Employees: 4
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

SciSparc Ltd. develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation. SCi-160 for the. treatment of pain; SCII-210 for the. treatment of autism spectrum disorder and epilepsy. The company was formerly known as Therapix Biosciences.

Recent news